JP2000503003A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000503003A5 JP2000503003A5 JP1997523703A JP52370397A JP2000503003A5 JP 2000503003 A5 JP2000503003 A5 JP 2000503003A5 JP 1997523703 A JP1997523703 A JP 1997523703A JP 52370397 A JP52370397 A JP 52370397A JP 2000503003 A5 JP2000503003 A5 JP 2000503003A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Description
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/577,106 US7354587B1 (en) | 1994-07-06 | 1995-12-22 | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| US08/577,106 | 1995-12-22 | ||
| PCT/US1996/019755 WO1997023237A1 (en) | 1995-12-22 | 1996-12-20 | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008016220A Division JP2008115196A (ja) | 1995-12-22 | 2008-01-28 | 多段階カスケード増強ワクチンの効果を高めるための免疫接合体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000503003A JP2000503003A (ja) | 2000-03-14 |
| JP2000503003A5 true JP2000503003A5 (ja) | 2004-11-04 |
Family
ID=24307306
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09523703A Withdrawn JP2000503003A (ja) | 1995-12-22 | 1996-12-20 | 多段階カスケード増強ワクチンの効果を高めるための免疫接合体の使用 |
| JP2008016220A Pending JP2008115196A (ja) | 1995-12-22 | 2008-01-28 | 多段階カスケード増強ワクチンの効果を高めるための免疫接合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008016220A Pending JP2008115196A (ja) | 1995-12-22 | 2008-01-28 | 多段階カスケード増強ワクチンの効果を高めるための免疫接合体 |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP2057999A3 (ja) |
| JP (2) | JP2000503003A (ja) |
| AU (1) | AU721927B2 (ja) |
| CA (1) | CA2240834C (ja) |
| WO (1) | WO1997023237A1 (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515052A (ja) * | 1997-08-13 | 2001-09-18 | ザ ユーエイビー リサーチ ファンデーション | 遺伝子ベクターの局所施用によるワクチン接種 |
| EP1032583A4 (en) * | 1998-03-06 | 2005-02-02 | Imclone Systems Inc | Active immunization against angiotens |
| CA2328528C (en) | 1998-05-20 | 2009-07-21 | Immunomedics, Inc. | Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| DE60042785D1 (de) * | 1999-06-09 | 2009-10-01 | Immunomedics Inc | Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern |
| JP2003514774A (ja) * | 1999-10-13 | 2003-04-22 | ロスウェル パーク メモリアル インスティテュート | 自己の腫瘍関連抗原に対する強い免疫応答の誘導 |
| JP4212921B2 (ja) | 2002-03-29 | 2009-01-21 | 独立行政法人科学技術振興機構 | 抗体を提示するタンパク質中空ナノ粒子を用いる治療薬剤およびタンパク質中空ナノ粒子 |
| TWI434855B (zh) * | 2006-11-21 | 2014-04-21 | Hoffmann La Roche | 結合物及其在免疫分析中作為參考標準之用途 |
| BRPI0812311A8 (pt) * | 2007-05-31 | 2019-02-05 | Academisch Ziekenhuis Leiden | uso de um peptídeo derivado da proteína e2, e6 e/ou e7 do hpv |
| TWI438675B (zh) | 2010-04-30 | 2014-05-21 | Ibm | 提供情境感知援助說明之方法、裝置及電腦程式產品 |
| CA2830349C (en) * | 2011-03-17 | 2019-07-16 | The University Of Birmingham | Re-directed immunotherapy |
| GB201203442D0 (en) | 2012-02-28 | 2012-04-11 | Univ Birmingham | Immunotherapeutic molecules and uses |
| WO2013139789A1 (en) * | 2012-03-19 | 2013-09-26 | Deutsches Krebsforschungszentrum | B-cell receptor complex binding proteins containing t-cell epitopes |
| GB201216649D0 (en) * | 2012-09-18 | 2012-10-31 | Univ Birmingham | Agents and methods |
| JP2018508481A (ja) | 2015-02-02 | 2018-03-29 | ザ ユニバーシティ オブ バーミンガム | 複数のｔ細胞エピトープを有する標的化部分ペプチドエピトープ複合体 |
| PT3377103T (pt) | 2015-11-19 | 2021-05-26 | Revitope Ltd | Complementação de fragmento de anticorpo funcional para um sistema de dois componentes para exterminação redirecionada de células indesejadas |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4361549A (en) | 1979-04-26 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human T cells, and methods of preparing same |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4818709A (en) | 1983-01-21 | 1989-04-04 | Primus Frederick J | CEA-family antigens, Anti-CEA antibodies and CEA immunoassay |
| US5851526A (en) * | 1985-04-19 | 1998-12-22 | Ludwig Institute For Cancer Research | Methods of treating colon cancer utilizing tumor-specific antibodies |
| US5525338A (en) | 1992-08-21 | 1996-06-11 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin conjugates |
| US4699784A (en) | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
| US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
| US5194254A (en) * | 1986-05-06 | 1993-03-16 | Connaught Laboratories Limited | Enhancement of antigen immunogenicity |
| GB8610983D0 (en) * | 1986-05-06 | 1986-06-11 | Connaught Lab | Enhancement of antigen immunogenicity |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| DK8189A (da) * | 1988-01-12 | 1989-07-13 | Bunge Australia | Antigen-antistof-konjugater, deres fremstilling og anvendelse |
| DE69030172T2 (de) | 1990-01-26 | 1997-06-19 | Immunomedics Inc | Impfstoffe gegen Krebs und Infektionskrankheiten |
| US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
| JPH10500670A (ja) * | 1994-05-13 | 1998-01-20 | エクラゲン リミテッド | ペプチド送達の改良またはペプチド送達との関連 |
| US5686578A (en) * | 1994-08-05 | 1997-11-11 | Immunomedics, Inc. | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| DE69637523D1 (de) * | 1995-06-07 | 2008-06-26 | Sanofi Pasteur Ltd | Chimäre antikörper zur abgabe von antigenen an selektierte zellen des immunsystems |
-
1996
- 1996-12-20 EP EP09002533A patent/EP2057999A3/en not_active Ceased
- 1996-12-20 CA CA2240834A patent/CA2240834C/en not_active Expired - Fee Related
- 1996-12-20 JP JP09523703A patent/JP2000503003A/ja not_active Withdrawn
- 1996-12-20 EP EP96943706A patent/EP0881910A4/en not_active Ceased
- 1996-12-20 WO PCT/US1996/019755 patent/WO1997023237A1/en active Application Filing
- 1996-12-20 AU AU12871/97A patent/AU721927B2/en not_active Ceased
-
2008
- 2008-01-28 JP JP2008016220A patent/JP2008115196A/ja active Pending